Get started
Author

Nicholaos A. Malamos

Molecular Detection of Cytokeratin-19–Positive Cells in the Peripheral Blood of Patients With Operable Breast Cancer: Evaluation of Their Prognostic Significance
2002 · A. Stathopoulou, I. Vlachonikolis, et al. · Journal of Clinical Oncology · 334
Six versus 12 months of adjuvant trastuzumab in combination with dose-dense chemotherapy for women with HER2-positive breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG)
2015 · D. Mavroudis, E. Saloustros, et al. · Annals of Oncology · 166
Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer
2003 · N. Xenidis, I. Vlachonikolis, et al. · Annals of Oncology · 98
PDF
Depression, anxiety and general psychopathology in breast cancer patients: a cross-sectional control study.
2010 · M Fafouti, T Paparrigopoulos, et al. · PubMed · 65
Pregnancy and Offspring after the Appearance of Breast Cancer
2009 · Nicholaos A. Malamos, George P. Stathopoulos, et al. · Oncology · 63
Erythropoietin enhances radiation treatment efficacy in patients with pelvic malignancies. final results of a randomized phase III study
2001 · D. Antonadou, E. Cardamakis, et al. · European Journal of Cancer · 47
Gemcitabine and vinorelbine as second-line therapy in non-small-cell lung cancer after prior treatment with taxane+platinum-based regimens
2001 · C Kosmas, N Tsavaris, et al. · European Journal of Cancer · 36
Dose-dense FEC followed by docetaxel versus docetaxel plus cyclophosphamide as adjuvant chemotherapy in women with HER2-negative, axillary lymph node-positive early breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG)
2016 · D. Mavroudis, A. Matikas, et al. · Annals of Oncology · 35
Evaluation of the paclitaxel–ifosfamide–cisplatin (TIP) combination in relapsed and/or metastatic cervical cancer
2009 · C Kosmas, N Mylonakis, et al. · British Journal of Cancer · 35
PDF
Paclitaxel combined with cis-platin as second-line treatment in patients with advanced non-small cell lung cancers refractory to cis-platin.
1999 · G P Stathopoulos, S Rigatos, et al. · Oncology Reports · 26
Phase I study of dose-escalated paclitaxel, ifosfamide, and cisplatin (PIC) combination chemotherapy in advanced solid tumours
2000 · C Kosmas, N B Tsavaris, et al. · British Journal of Cancer · 23
PDF
Irinotecan combined with docetaxel in pre-treated metastatic breast cancer patients: a phase II study
2005 · G. P. Stathopoulos, D. Tsavdaridis, et al. · Cancer Chemotherapy and Pharmacology · 20
Predictive value of ATP7b, BRCA1, BRCA2, PARP1, UIMC1 (RAP80), HOXA9, DAXX, TXN (TRX1), THBS1 (TSP1) and PRR13 (TXR1) genes in patients with epithelial ovarian cancer who received platinum-taxane first-line therapy
2016 · S Pontikakis, C Papadaki, et al. · The Pharmacogenomics Journal · 17
Oxaliplatin in Combination with Infusional 5-Fluorouracil and Leucovorin Every 2 Weeks as First-Line Treatment in Patients with Advanced Colorectal Cancer: A Phase II Study
2001 · Ch. Kouroussis, J. Souglakos, et al. · Oncology · 17
Inhibition of adriamycin cardiotoxicity by 5-fluorouracil: a potential free oxygen radical scavenger.
1998 · G P Stathopoulos, N A Malamos, et al. · PubMed · 16
Weekly administration of topotecan–paclitaxel as second-line treatment in ovarian cancer
2006 · G. P. Stathopoulos, N. A. Malamos, et al. · Cancer Chemotherapy and Pharmacology · 13
Phase I–II study of docetaxel and ifosfamide combination in patients with anthracycline pretreated advanced breast cancer
2003 · C Kosmas, N Tsavaris, et al. · British Journal of Cancer · 10
PDF
Maintenance chemotherapy or not in ovarian cancer stages IIIA, B, C, and IV after disease recurrence.
2012 · G P Stathopoulos, Ch Papadimitriou, et al. · PubMed · 8
Chemo-radiotherapy versus chemo-surgery in stage IIIA non-small cell lung cancer
1996 · G Stathopoulos, P Papakostas, et al. · Oncology Reports · 7
Docetaxel-Ifosfamide Combination in Patients with Advanced Breast Cancer Failing Prior Anthracycline- Based Regimens: Results of a Phase I-II Study
2007 · C. Kosmas, N. Tsavaris, et al. · Journal of Chemotherapy · 6
Gemcitabine plus Irinotecan in Breast Cancer Patients Pretreated with Taxanes and Anthracyclines: A Multicenter Phase II Study
2003 · S. Agelaki, E. Karyda, et al. · Oncology · 6
Final results of a randomized phase II study evaluating the role of erythropoietin during radiochemotherapy for pelvic tumors
2004 · N. Throuvalas, D. Antonadou, et al. · International Journal of Radiation Oncology*Biology*Physics · 5
PDF
Pregnancy and Offspring After the Appearance of Breast Cancer
1997 · Nicholaos A. Malamos, George P. Stathopoulos, et al. · Obstetrical & Gynecological Survey · 5
122 Comparative study between exclusive irradiation or combined with IFN-α-2a and isotretinoin in stage IIB and III cervical carcinoma
1996 · D. Antonadou, E. Cardamakis, et al. · International Journal of Radiation Oncology*Biology*Physics · 5
PDF
Randomized phase III trial comparing the sequential administration of docetaxel followed by epirubicin plus cyclophosphamide versus FE75C as adjuvant chemotherapy in axillary lymph node-positive breast cancer
2008 · D. Mavroudis, N. Malamos, et al. · Journal of Clinical Oncology · 4
Works count: 47
Citation count: 1,078
H-index: 15
I10-index: 17
Year
Topic
Type